# Specification Quality Checklist: Carbohydrates and Diabetes (Tietz ch 22/33), gaps only

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-11-13
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- Like specs/020–024, this project's specs name engine files and Lab Notebook entries (the N-numbers, `refs.js`, `PRINTED_FIRST_KEYS`). That is the house convention for clinical specs: the reviewer needs to know which owner each item duplicates. It is accepted here and not treated as a leak.
- The insulin and C-peptide fallback ranges were not checked against a document this session. They are fallback-only and reviewer-gated under P143.
